| Primary |
| Drug Use For Unknown Indication |
20.4% |
| Product Used For Unknown Indication |
18.3% |
| Cytomegalovirus Infection |
10.8% |
| Transplant |
6.5% |
| Prophylaxis |
5.4% |
| Antiretroviral Therapy |
4.3% |
| Congenital Cystic Kidney Disease |
4.3% |
| Lung Transplant |
4.3% |
| Renal Transplant |
4.3% |
| Immunosuppression |
3.2% |
| Urinary Tract Infection |
3.2% |
| Anaemia |
2.2% |
| Cerebral Toxoplasmosis |
2.2% |
| Neutropenia |
2.2% |
| Pneumocystis Jiroveci Infection |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Antiviral Prophylaxis |
1.1% |
| Aplastic Anaemia |
1.1% |
| Chronic Lymphocytic Leukaemia |
1.1% |
| Depression |
1.1% |
|
| Agranulocytosis |
9.7% |
| Hepatic Steatosis |
9.7% |
| Acute Leukaemia |
6.5% |
| Deafness |
6.5% |
| Hypoacusis |
6.5% |
| Neutropenia |
6.5% |
| Renal Failure Acute |
6.5% |
| Vomiting |
6.5% |
| White Blood Cell Count Decreased |
6.5% |
| Angioedema |
3.2% |
| Cholestasis |
3.2% |
| General Physical Condition Abnormal |
3.2% |
| Generalised Erythema |
3.2% |
| Guillain-barre Syndrome |
3.2% |
| Mania |
3.2% |
| Mouth Ulceration |
3.2% |
| Pain In Extremity |
3.2% |
| Pancreatitis |
3.2% |
| Pancreatitis Acute |
3.2% |
| Quadriparesis |
3.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.0% |
| Renal Transplant |
14.2% |
| Prophylaxis |
10.7% |
| Hiv Infection |
9.7% |
| Cytomegalovirus Infection |
7.4% |
| Product Used For Unknown Indication |
6.7% |
| Cord Blood Transplant Therapy |
4.6% |
| Depression |
2.6% |
| Unevaluable Event |
2.6% |
| Diarrhoea |
2.3% |
| Hypertension |
2.3% |
| Insomnia |
2.1% |
| Mycobacterium Avium Complex Infection |
2.1% |
| Antifungal Prophylaxis |
1.6% |
| Bone Marrow Transplant |
1.6% |
| Cytomegalovirus Colitis |
1.6% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Anxiety |
1.4% |
| Aspergillus Infection |
1.4% |
| Cholestasis |
1.4% |
|
| Agranulocytosis |
13.4% |
| Thrombocytopenia |
9.8% |
| Viral Infection |
9.8% |
| Pyrexia |
7.3% |
| Neutropenia |
6.1% |
| Thrombotic Microangiopathy |
6.1% |
| Leukopenia |
4.9% |
| Renal Failure Acute |
4.9% |
| Febrile Neutropenia |
3.7% |
| Lung Disorder |
3.7% |
| Pancytopenia |
3.7% |
| Quadriparesis |
3.7% |
| Renal Failure |
3.7% |
| Tubulointerstitial Nephritis |
3.7% |
| Vomiting |
3.7% |
| Bone Marrow Toxicity |
2.4% |
| Oesophageal Candidiasis |
2.4% |
| Pleural Effusion |
2.4% |
| Weight Decreased |
2.4% |
| Wound Dehiscence |
2.4% |
|
| Concomitant |
| Renal Transplant |
17.5% |
| Hiv Infection |
17.2% |
| Drug Use For Unknown Indication |
11.9% |
| Product Used For Unknown Indication |
8.1% |
| Prophylaxis Against Transplant Rejection |
5.4% |
| Prophylaxis |
4.9% |
| Hypertension |
3.6% |
| Liver Transplant |
3.6% |
| Tuberculosis |
3.6% |
| Cytomegalovirus Infection |
3.5% |
| Transplant |
2.5% |
| Diarrhoea |
2.4% |
| Mycobacterium Avium Complex Infection |
2.4% |
| Anaemia |
2.3% |
| Immunosuppression |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Pain |
1.9% |
| Mycobacterial Infection |
1.8% |
| Angina Pectoris |
1.4% |
| Mitochondrial Toxicity |
1.4% |
|
| Transplant Rejection |
15.7% |
| Renal Failure |
7.4% |
| Pyrexia |
6.5% |
| Urinary Tract Infection |
6.5% |
| Vena Cava Thrombosis |
5.6% |
| Leukopenia |
4.6% |
| Lung Disorder |
4.6% |
| Tubulointerstitial Nephritis |
4.6% |
| Vomiting |
4.6% |
| Pancytopenia |
3.7% |
| Postrenal Failure |
3.7% |
| Rash Maculo-papular |
3.7% |
| Renal Failure Acute |
3.7% |
| Sepsis |
3.7% |
| Septic Shock |
3.7% |
| Subdural Haematoma |
3.7% |
| Thrombocytopenia |
3.7% |
| Urosepsis |
3.7% |
| Weight Decreased |
3.7% |
| Hepatocellular Injury |
2.8% |
|
| Interacting |
| Liver Transplant |
66.7% |
| Aspergillosis |
33.3% |
|
| Prothrombin Level Decreased |
100.0% |
|
